HPV: What You Need to Know About Symptoms, Testing, and Treatment

Yes. The immune system clears most HPV infections within one to two years without treatment. Approximately 90% of HPV infections resolve spontaneously. However, persistent infections with high-risk types can lead to precancerous changes over years to decades, which is why regular screening is important.

Most HPV infections have no symptoms. Low-risk types may cause visible genital warts. High-risk types are detected through screening tests (HPV test performed during cervical cancer screening). There is no approved HPV blood test. For people without a cervix, there is no routine HPV screening — the virus is usually detected only if warts develop or abnormal cells are found.

The HPV vaccine (Gardasil 9) is approved for ages 9 through 45. It is most effective before HPV exposure, ideally at ages 11-12. However, vaccination can still provide benefit for adults up to age 45 who have not been exposed to all vaccine-covered types. Discuss with your provider whether vaccination is appropriate for your situation.

Yes. Telehealth is excellent for HPV-related concerns including discussing abnormal Pap or HPV results, counseling about vaccination, prescribing treatments for genital warts, answering questions about transmission and prevention, and coordinating follow-up screening. Physical examination for warts may require an in-person visit.

Open communication with partners is encouraged. HPV is extremely common — most sexually active people contract it at some point. There is no way to determine exactly when or from whom you acquired it. Discussing HPV allows partners to make informed decisions about screening, vaccination, and monitoring their own health.

An abnormal result usually means HPV-related cell changes were detected, not cancer. Common findings include ASC-US, LSIL, or HSIL, each with a defined follow-up plan such as repeat testing in 12 months, HPV reflex testing, or colposcopy. Your provider will explain your specific result and the recommended next step based on current ASCCP guidelines.

Genital warts can be treated with prescription topicals such as imiquimod or podofilox applied at home, or with in-office procedures like cryotherapy, trichloroacetic acid, or surgical removal. Treatment clears visible warts but does not eliminate the underlying HPV. Recurrence is common, and a healthy immune system clears most infections over time.

Yes. HPV is linked to cancers of the penis, anus, and oropharynx (back of the throat) in men. HPV-related oropharyngeal cancer rates have been rising and are now more common in men than women. The HPV vaccine reduces this risk and is recommended through age 26, with shared decision making up to age 45.

Condoms reduce but do not eliminate HPV transmission, because the virus can infect skin not covered by the condom. Consistent condom use lowers the risk of HPV transmission, genital warts, and cervical changes. The most effective prevention is HPV vaccination before sexual exposure, ideally between ages 9 and 12.

Yes. For patients 12 and older in Maryland, Washington, and Delaware, Innocre can review prior Pap and HPV results, explain your guideline-based follow-up timeline, send referrals for colposcopy when indicated, and discuss HPV vaccination eligibility. Pap collection itself must be done in person, but counseling and care coordination are well-suited to telehealth.